Extended knowledge of 763114-25-6

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 763114-25-6, help many people in the next few years.category: benzofuran

In heterogeneous catalysis, the catalyst is in a different phase from the reactants. category: benzofuran, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 763114-25-6, name is 2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile. In an article,Which mentioned a new discovery about 763114-25-6

The histamine H4 receptor (H4R), a member of the G-protein coupled receptor family, has been considered as a potential therapeutic target for treating atopic dermatitis (AD). A large number of H4R antagonists have been disclosed, but no efficient agents controlling both pruritus and inflammation in AD have been developed yet. Here, we have discovered a novel class of orally available H4R antagonists showing strong anti-itching and anti-inflammation activity as well as excellent selectivity against off-targets. A pharmacophore-based virtual screening system constructed in-house successfully identified initial hit compound 9, and the subsequent homology model-guided optimization efficiently led us to discover pyrido[2,3-e]tetrazolo[1,5-a]pyrazine analogue 48 as a novel chemotype of a potent and highly selective H4R antagonist. Importantly, orally administered compound 48 exhibits remarkable efficacy on antipruritus and anti-inflammation with a favorable pharmacokinetic (PK) profile in several mouse models of AD. Thus, these data strongly suggest that our compound 48 is a promising clinical candidate for treatment of AD.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 763114-25-6, help many people in the next few years.category: benzofuran

Reference:
Benzofuran – Wikipedia,
Benzofuran | C8H4001O – PubChem